SCHEMBL25440267

SCHEMBL25440267

Cc1ccc(N(c2cccc(C)c2)C(C(=O)OC(C)C)C(=O)OC(C)C)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B1 P14061 6/20 0.42
HSD17B2 P37059 6/20 0.42
ALDH1A1 P00352 5/20 0.38
MAPT P10636 3/20 0.38
HTT P42858 2/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
POLQ O75417 1/20 0.36
MAPK1 P28482 1/20 0.35
TP53 P04637 2/20 0.35
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
PAX8 Q06710 2/20 0.35
GPX4 P36969 1/20 0.35
ALOX5 P09917 1/20 0.35
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CA7 P43166 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25439798 0.88 TRPM8 (0.40) ALDH1A1MAPTHTTMEN1KMT2A
SCHEMBL25439936 0.88 ALOX5 (0.42) ALDH1A1HTTNPSR1RAB9AALOX5
SCHEMBL26324953 0.86 HSD17B1 (0.40) HSD17B1HSD17B2ALDH1A1MAPTHTT
SCHEMBL26327831 0.81 ALDH1A1 (0.41) HSD17B1HSD17B2ALDH1A1MAPTHTT
SCHEMBL25440144 0.80 TSHR (0.44) ALDH1A1MAPTHTTKMT2ANPSR1
SCHEMBL25440020 0.79 PDCD1 (0.40) HSD17B1HSD17B2MAPTHTTKMT2A
SCHEMBL20565053 0.78 MEN1 (0.39) MAPTMEN1KMT2ANPSR1MAPK1
SCHEMBL25439930 0.77 PDCD1 (0.46) MAPT
SCHEMBL25439854 0.77 PDCD1 (0.53) ALDH1A1MAPTHTTKMT2ANPC1
SCHEMBL20564588 0.76 ALOX5 (0.41) HSD17B1HSD17B2HTTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11767291-B2 Preparation of secondary amines with electrophilic N-linchpin reagents WILLIAM MARSH RICE UNIVERSITY (US) 2023-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11767291-B2 Preparation of secondary amines with electrophilic N-linchpin reagents PNMT, NCL, NPM1 HSD17B1 4720/4885HSD17B2 4306/4885ALDH1A1 1805/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.